ResearcherCentral South UniversityNo recent work listed

Gouling Zhan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9122-8523; OpenAlex author ID A5016206113. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer. Co-author DOI 10.3389/fendo.2023.1110624 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuqi Su · 1 shared paper, 2023 · strength 0.16
- Paper A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer. DOI 10.3389/fendo.2023.1110624 ↗
Min Xu · 1 shared paper, 2023 · strength 0.16
- Paper A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer. DOI 10.3389/fendo.2023.1110624 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.